Seaward Management Limited Partnership raised its position in Johnson & Johnson (NYSE:JNJ) by 0.2% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 291,254 shares of the company’s stock after purchasing an additional 529 shares during the period. Johnson & Johnson makes up about 1.9% of Seaward Management Limited Partnership’s investment portfolio, making the stock its 15th biggest holding. Seaward Management Limited Partnership’s holdings in Johnson & Johnson were worth $38,530,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of the business. Lenox Wealth Advisors Inc. boosted its holdings in shares of Johnson & Johnson by 0.6% in the second quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock valued at $116,000 after buying an additional 5 shares during the period. Harel Insurance Investments & Financial Services Ltd. boosted its holdings in shares of Johnson & Johnson by 241.0% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,190 shares of the company’s stock valued at $149,000 after buying an additional 841 shares during the period. Ullmann Financial Group Inc. acquired a new position in shares of Johnson & Johnson in the first quarter valued at approximately $186,000. Puplava Financial Services Inc. acquired a new position in shares of Johnson & Johnson in the second quarter valued at approximately $202,000. Finally, Hutchens Investment Management Inc acquired a new position in shares of Johnson & Johnson in the first quarter valued at approximately $204,000. 65.93% of the stock is owned by hedge funds and other institutional investors.
Shares of Johnson & Johnson (JNJ) opened at $138.00 on Friday. The company has a market cap of $370,739.75, a price-to-earnings ratio of 19.33, a price-to-earnings-growth ratio of 2.80 and a beta of 0.82. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.32 and a quick ratio of 1.02. Johnson & Johnson has a 12 month low of $109.32 and a 12 month high of $144.35.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Tuesday, November 28th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 2.43%. The ex-dividend date is Monday, November 27th. Johnson & Johnson’s dividend payout ratio is currently 58.33%.
JNJ has been the subject of several research analyst reports. Goldman Sachs Group, Inc. (The) cut shares of Johnson & Johnson from a “neutral” rating to a “sell” rating and upped their price target for the company from $125.00 to $130.00 in a report on Wednesday, September 20th. BMO Capital Markets reiterated a “buy” rating and issued a $145.00 price target on shares of Johnson & Johnson in a report on Friday, September 1st. Vetr upgraded shares of Johnson & Johnson from a “sell” rating to a “hold” rating and set a $137.71 price target for the company in a report on Monday, October 30th. Credit Suisse Group set a $154.00 price target on shares of Johnson & Johnson and gave the company an “outperform” rating in a report on Thursday, October 19th. Finally, UBS AG reiterated an “underweight” rating on shares of Johnson & Johnson in a report on Thursday, August 24th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and eleven have given a buy rating to the company. Johnson & Johnson has an average rating of “Hold” and an average price target of $143.70.
About Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.